Retrospective, Multicenter Study of Lacosamide to Treat Neonatal Seizures
ABSTRACT Objective Most antiseizure medications (ASMs) are prescribed off label for neonates. Lacosamide's efficacy in infants and availability in intravenous formulation suggest potential utility for neonates. We evaluated the safety and efficacy of lacosamide for neonatal seizures. Methods This 10‐center, retrospective study of neonates with seizures
Alexandra Santana Almansa +15 more
wiley +1 more source
Prevalence and factors associated with preterm small-for-gestational-age neonates: a multi-center survey in China. [PDF]
Zhang YJ, Chen C.
europepmc +1 more source
Mothers with Alcoholic Liver Disease and the Risk for Preterm and Small-for-gestational-age Birth [PDF]
Knut Stokkeland +4 more
openalex +1 more source
Early‐Life Clinical Factors Shape Cerebellar Structure in Preterm‐Born Children
ABSTRACT Objective Preterm birth alters typical brain development due to complex exposures related to neonatal illness, pain management, and brain injury. Despite an increased understanding of neonatal brain injury on developmental outcomes, the association of cerebellar maturation with school‐age motor and cognitive function remains incompletely ...
Victoria Rapos +6 more
wiley +1 more source
Abandon Use of “Small for Gestational Age”? Is It Too Soon?
Xinyu Shu +5 more
openalex +1 more source
Acylated Ghrelin, Growth Hormone and IGF-1 Levels in the Cord Blood of Small for Gestational Age Newborns [PDF]
Nastaran Khosravi +6 more
openalex +1 more source
Fetal Pain Perception: Legislative Assertions and Developmental Neuroscience
ABSTRACT Background Pain perception is a conscious experience, but neither pain nor consciousness is defined in the developing human fetus. Emergent consciousness may be regarded as a phenomenon that ultimately arises from an essential minimum of functional neuronal connectivity. Proposed U.S.
William D. Graf +9 more
wiley +1 more source
Prevalence and maternal risk factors of small for gestational age infants born at a regional centre in Australia: a retrospective study. [PDF]
Othman A +4 more
europepmc +1 more source
Population Pharmacokinetics of Clesrovimab in Preterm and Full‐Term Infants
Clesrovimab is a half‐life extended monoclonal antibody targeting the respiratory syncytial virus fusion protein. Three studies (phase Ib/IIa [MK‐1654‐002], phase IIb/III [CLEVER], and phase III [SMART]) were conducted to evaluate the efficacy, safety, and pharmacokinetics (PK) of clesrovimab in infants.
Ziheng Hu +8 more
wiley +1 more source

